Jack Nathan Mexico Update
Jack Nathan Medical Corp (TSXV: JNH; OTCQB: JNHMF) announces critical developments regarding its Mexico operations.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
As reported in the Company’s March 19, 2025 press release, JNH Mexico has been unable to ratify terms for continuity of business with Walmart Mexico, and the Company had notified Walmart Mexico to consider evaluating all strategic options, including: (a) consenting to permit JNH to sell it’s
The Company is continuing to explore strategic options for continuity of operations in
If an agreement for a commercial or M&A transaction for JNH Mexico is signed, further details will be provided by the Company at that time. No assurances can be provided that any of these efforts will be successful. In the absence of being able to secure such an agreement, the Company is facing a wind down scenario of its
About Jack Nathan Medical Corp.
Jack Nathan Health®, a pioneer in the healthcare industry, became one of
Established in 2006, Jack Nathan Health® has grown its international footprint, delivering state-of-the-art, turn-key medical centers. Currently, the Company operates 175 locations globally, all corporately owned and operated. In
For more information, visit www.jnhmexico.com or www.sedarplus.ca.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Concerning Going Concern
As previously reported by the Company in its consolidated financial statements and related management’s discussion and analysis filed on SEDAR+ (www.sedarplus.ca), the Company requires additional financing to enable it to continue operations. In the absence of additional financing in the near term, the Company is not expected to have sufficient funds to meet its obligations. The Company is actively pursuing alternatives to raise the necessary additional financing. There can be no assurances that the Company will be able to secure the necessary financing to enable it to continue as a going concern.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250404589452/en/
Jack Nathan Medical Corp., Mike Marchelletta, Chief Executive Officer; phone: (416) 518-1000.
Source: Jack Nathan Medical Corp.